Richmond Behavioral Associates
Part of the ERG Network of Research Sites
Richmond Behavioral Associates
Richmond Behavioral Associates (RBA) is your premier destination for cutting-edge treatments in clinical psychopharmacology. Our expertise in psychiatric medications, combined with extensive experience conducting clinical trials in Depression, Bipolar Disorder, Schizophrenia, Alzheimer’s Disease, Autism, and Anxiety, ensures our patients have access to the latest advancements in pharmaceuticals. RBA has partnered with major pharmaceutical companies such as Allergan, Astra-Zeneca, Bristol Myers Squibb, Eli Lilly, Johnson and Johnson, Pfizer, Roche-Genentech, and Sanofi-Aventis, among others, to conduct groundbreaking trials. As a service-oriented organization, RBA prioritizes quality care and provides excellent patient follow-up, making us your trusted partner in mental health treatment.
Conditions We Research:
- Depression
- Anxiety
- Bipolar disorder
- Schizophrenia
- Autism
- Alzheimer’s Disease
- Insomnia
- Central Nervous System Conditions
Our Clinical Research Facilities
Staten Island, NY Location
- 5,000 square feet
- 2 Dedicated monitoring offices
- 2 examination/testing rooms
- 1 Dedicated drug room
- All ECGs, blood pressure, centrifuges, thermometers, stadiometer calibrated on 6-month basis
- -20 degree centigrade freezer (daily access to dry ice)
- -20 degree refrigerated centrifuge
- 2 Board certified Psychiatrists, inclusive Geriatric Psychiatry Boards
- 1 Board eligible Child Psychiatrist (taking boards)
- 1 Licensed Psychologist/Neuropsychologist
- 4 Full Time Study Coordinators (2 CCRC certified)
- 2 Data Entry Specialists
- 1 Regulatory/Marketing specialist
- Sub I Board certified Ophthalmologist for any eye examinations necessary (optovue)